Altered CELF1 binding to target transcripts in malignant T cells

Area of Science:

• Molecular Biology
• Cancer Biology
• Immunology

Background:

• The RNA-binding protein CELF1 (CUGBP Elav-like family member 1) regulates mRNA targets involved in cell activation, proliferation, and apoptosis.
• CELF1 binds to GU-rich elements (GREs) in mRNA sequences.
• Dysregulation of CELF1 is implicated in various cellular processes and diseases.

Purpose of the Study:

• To investigate the role of CELF1 binding to mRNA targets in normal versus malignant T cells.
• To determine how CELF1 phosphorylation affects its binding and regulation of target transcripts in T-cell malignancies.
• To identify specific CELF1-regulated transcripts that contribute to the malignant phenotype in T-cell acute lymphoblastic leukemia (T-ALL).

Main Methods:

• Immunoprecipitation using an anti-CELF1 antibody.
• Identification of copurified transcripts using microarrays.
• Analysis of CELF1 phosphorylation status in normal and malignant T cells.
• Correlation of CELF1 binding with mRNA stability and expression levels.

Main Results:

• CELF1 targets distinct mRNA sets in malignant T cells compared to primary T cells.
• Phosphorylated CELF1 in malignant T cells shows reduced binding to GRE-containing mRNAs.
• This reduced binding leads to stabilization and upregulation of cell growth-promoting transcripts, and degradation/downregulation of cell growth-suppressing transcripts.
• Upregulated growth-promoting transcripts were also observed in primary T-ALL tumors.

Conclusions:

• CELF1 dysfunction, characterized by altered phosphorylation and binding, contributes to a malignant T-cell phenotype.
• The aberrant regulation of specific mRNA subsets by CELF1 drives both oncogenic and tumor-suppressive pathways in T-ALL.
• Targeting CELF1 or its regulatory pathways may offer therapeutic strategies for T-cell malignancies.